Search Results

Editorial

Authors: Wainwright, CL; McGrath, JC

Source: British Journal of Pharmacology, Volume 158, Number 2, September 2009 , pp. 393-394(2)

Publisher: Blackwell Publishing

Inhibition of stearoyl-CoA desaturase by cyclic amine derivatives

Authors: Dobrzyn, Agnieszka; Dobrzyn, Pawel

Source: Expert Opinion on Therapeutic Patents, Volume 18, Number 4, April 2008 , pp. 457-460(4)

Publisher: Informa Healthcare

Adiponectin and its Role in Cardiovascular Diseases

Authors: Beltowski, Jerzy; Jamroz-Wisniewska, Anna; Widomska, Sylwia

Source: Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current D, Volume 8, Number 1, March 2008 , pp. 7-46(40)

Publisher: Bentham Science Publishers

Impact of Weight-Loss Medications on the Cardiovascular System: Focus on Current and Future Anti-Obesity Drugs

Authors: Drolet, Benoit; Simard, Chantale; Poirier, Paul

Source: American Journal of Cardiovascular Drugs, Volume 7, Number 4, 2007 , pp. 273-288(16)

Publisher: Adis International

Adipocyte prolactin: regulation of release and putative functions

Authors: Brandebourg; Hugo; Ben-Jonathan

Source: Diabetes, Obesity and Metabolism, Volume 9, Number 4, July 2007 , pp. 464-476(13)

Publisher: Blackwell Publishing

Somatostatin, a negative-regulator of central leptin action in the rat hypothalamus

Authors: Stepanyan, Z.; Kocharyan, A.; Behrens, M.; Koebnick, C.; Pyrski, M.; Meyerhof, W.

Source: Journal of Neurochemistry, Volume 100, Number 2, January 2007 , pp. 468-478(11)

Publisher: Blackwell Publishing

The Melanocortin System as a Therapeutic Treatment Target for Adiposity and Adiposopathy

Author: Bays, Harold

Source: Drugs in R&D, Volume 7, Number 5, 2006 , pp. 289-302(14)

Publisher: Adis International

Investigational therapies in the treatment of obesity

Authors: Mancini, Marcio C; Halpern, Alfredo

Source: Expert Opinion on Investigational Drugs, Volume 15, Number 8, August 2006 , pp. 897-915(19)

Publisher: Informa Healthcare

Melanocortin Receptors as Drug Targets for Disorders of Energy Balance

Authors: Adan, Roger A.H.; Dijk, Gertjan v.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 5, Number 3, June 2006 , pp. 251-261(11)

Publisher: Bentham Science Publishers

Ghrelin and Energy Balance: Focus on Current Controversies

Authors: David E. Cummings; Karen E. Foster-Schubert; Joost Overduin

Source: Current Drug Targets, Volume 6, Number 2, March 2005 , pp. 153-169(17)

Publisher: Bentham Science Publishers

Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor

Authors: Ghigo, E.; Broglio, F.; Arvat, E.; Maccario, M.; Papotti, M.; Muccioli, G.

Source: Clinical Endocrinology, Volume 62, Number 1, January 2005 , pp. 1-17(17)

Publisher: Blackwell Publishing

Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action

Authors: Gualillo O.; Lago F.; Gomez-Reino J.; Casanueva F.F.; Dieguez C.

Source: FEBS Letters, Volume 552, Number 2, 25 September 2003 , pp. 105-109(5)

Publisher: Elsevier

Di / tri-Peptide Transporters as Drug Delivery Targets: Regulation of Transport Under Physiological and Patho-physiological Conditions

Authors: Nielsen C.U.; Brodin B.

Source: Current Drug Targets, Volume 4, Number 5, july 2003 , pp. 373-388(16)

Publisher: Bentham Science Publishers

The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones

Author: Arner P.

Source: Trends in Endocrinology and Metabolism, Volume 14, Number 3, April 2003 , pp. 137-145(9)

Publisher: Elsevier

ACTH and -MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway

Authors: Norman D.; Isidori A.M.; Frajese V.; Caprio M.; Chew S.L.; Grossman A.B.; Clark A.J.; Michael Besser G.; Fabbri A.

Source: Molecular and Cellular Endocrinology, Volume 200, Number 1, 28 February 2003 , pp. 99-109(11)

Publisher: Elsevier

Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition

Authors: Azzara A.V.; Sokolnicki J.P.; Schwartz G.J.

Source: Physiology and Behavior, Volume 77, Number 2, November 2002 , pp. 411-416(6)

Publisher: Elsevier

Diet-induced obesity increases opioid receptor binding in specific regions of the rat brain

Authors: Smith S.L.; Harrold J.A.; Williams G.

Source: Brain Research, Volume 953, Number 1, 25 October 2002 , pp. 215-222(8)

Publisher: Elsevier

Characterization of leptin binding in bovine kidney membranes

Authors: Margetic S.; Gazzola C.; Pegg G.G.; Hill R.A.

Source: Domestic Animal Endocrinology, Volume 23, Number 3, October 2002 , pp. 411-424(14)

Publisher: Elsevier

Genetics of Obesity

Authors: Clement K.; Boutin P.; Froguel P.

Source: American Journal of PharmacoGenomics, Volume 2, Number 3, 2002 , pp. 177-187(11)

Publisher: Adis International

Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction?

Author: Gundlach A.L.

Source: European Journal of Pharmacology, Volume 440, Number 2, 12 April 2002 , pp. 255-268(14)

Publisher: Elsevier